Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6882
Rank
S$0.77 B
Marketcap
S$38.84
Share price
2.60%
Change (1 day)
-19.46%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total debt

Total debt on the balance sheet as of September 2025 : S$21.17 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total debt is S$21.17 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Avalon Pharma (Middle East Pharmaceutical) - Total debt on balance sheet (from 2023 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$23.72 M8.5%
2023-12-31S$21.86 M